An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017

Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Patrick Vermersch, Laurent Suchet, Renato Colamarino, Caroline Laurendeau, Bruno Detournay
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research